Chundsell Medicals
The company Chundsell Medicals was founded as a spin off from Cancer Center Karolinska in order to transfer the research results of Dr. Chunde Li and his group into clinical reality.
Contact
chundsell.com
Incubate 2010
About 90 percent of prostate cancers are non-aggressive whereas the rest are aggressive tumours, which have to be treated with radical methods. Present diagnostics can’t separate these forms which bring about severe decisions. This dilemma is the basis for the novel test PCPT (Prostate Cancer Prediction Test).